Seegene and BD team up for PCR testing; Soon-Shiong's NantOmics nabs proteomics Dx lab;

> Seegene and Becton, Dickinson and Company's ($BDX) BD Life Sciences unit are collaborating to develop real-time PCR tests for BD's molecular diagnostics platform. Statement

> Dr. Patrick Soon-Shiong's molecular diagnostic company NantOmics is snatching up proteomics diagnostic lab OncoPlex Diagnostics to gain ground in cancer testing. More

> Illumina ($ILMN) is teaming up with molecular diagnostics outfit Asuragen to develop sequencing-based companion diagnostics for biotech and pharma partners. Statement

> Texas-based True Health Diagnostics won its $37.1 million bid for bankrupt Health Diagnostics Laboratory. Story

> The U.K.'s National Health Service (NHS) unveiled a new initiative to accelerate cancer diagnosis for patients. Article

And Finally… Taking a big-data approach to genomics could speed up diagnosis for patients with rare diseases, according to some experts in the field. Story

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.